- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/10 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 243/10
Total number of patents in this class: 74
10-year publication summary
|
4
|
4
|
5
|
4
|
10
|
1
|
6
|
3
|
4
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nippon Chemiphar Co., Ltd. | 225 |
12 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
4 |
| Novartis AG | 10327 |
3 |
| Gilead Sciences, Inc. | 2189 |
3 |
| Kyushu University, National University Corporation | 1692 |
3 |
| Neuropore Therapies, Inc. | 32 |
3 |
| Merck Sharp & Dohme LLC | 3729 |
3 |
| Purdue Research Foundation | 3856 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2648 |
2 |
| Eagle Pharmaceuticals, Inc. | 106 |
2 |
| ImmunoGen, Inc. | 382 |
2 |
| TONIX Pharmaceuticals Holding Corp | 32 |
2 |
| Tonix Pharmaceuticals, Inc. | 43 |
2 |
| Bristol-myers Squibb Company | 4811 |
1 |
| Boehringer Ingelheim International GmbH | 4509 |
1 |
| Bayer Pharma AG | 1026 |
1 |
| The Regents of the University of Michigan | 4918 |
1 |
| Takeda Pharmaceutical Company Limited | 2718 |
1 |
| Alkermes Pharma Ireland Limited | 256 |
1 |
| Asubio Pharma Co., Ltd. | 20 |
1 |
| Other owners | 24 |